Western Standard Hedges With Biotech TradeMark Melin
Eric Andersen and Robert Wallendorf, portfolio manager and director of research respectively at Western Standard Partners, have a portfolio objective in 2018. The Los Angeles-based long/short hedge fund, up 2.6% as of March, is beating the Russell 2000, which is down 0.1%, through stock selection and creating a “margin of safety,” borrowing a technique from legendary value investor Seth Klarman. In their March letter to investors reviewed by ValueWalk they explain their reasons for a short hedge.
“The partnership’s goal for the second quarter of . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click Chat.